Trademark Overview
On Tuesday, October 21, 2025, a trademark application was filed for PENCIL BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the PENCIL BIOSCIENCES trademark a serial number of 99453404. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, October 21, 2025. This trademark is owned by Pencil Biosciences Ltd. The PENCIL BIOSCIENCES trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Biological preparations in the nature of eukaryotic cells, cell lines and bio-production cell lines generated using gene editing and gene modifying engineering for scientific, laboratory, clinical or medical research; reagents, enzymes, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate gene editing components including nucleic acid sequences, RNA, mRNA, rRNA, gRNA, protein, nuclease, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory, clinical or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for use in research and development, in vitro or in vivo use in biotechnology, and for clinical and commercial use.
Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical use; vectors for the delivery of genes to cells, all for medical purposes; genetically modified cells for medical use; vectors for the delivery of genes to cells for medical purposes; cell cultures, peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, mRNA or complexes of these molecules for medical and commercial use.
Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology services, advisory services relating to cell therapy and gene therapy products: consultancy and advisory services relating to the aforesaid services.
